Literature DB >> 26831013

Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy.

Miho Shimizu1, Kengo Furuichi, Tadashi Toyama, Junya Yamahana, Ryunosuke Ohkawa, Koji Igarashi, Junken Aoki, Shuichi Kaneko, Yutaka Yatomi, Takashi Wada.   

Abstract

Objective We evaluated the relationships between the serum autotaxin (ATX) levels and the clinical and pathological parameters, as well as the long-term renal outcome, in type 2 diabetic patients with biopsy-proven diabetic nephropathy. Methods In this retrospective single-center cohort study, serum samples were collected from 38 Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy at the time of renal biopsy. The serum ATX levels were measured using a specific sandwich enzyme immunoassay. Results A multivariate linear regression analysis revealed the urinary protein excretion to be independently associated with the serum ATX levels. In addition, patients with serum ATX levels above the median showed more advanced diffuse lesions, nodular lesions and arteriolar hyalinosis compared to those with serum ATX levels below the median. However, high serum ATX levels were not associated with any increase in the number of renal composite events [a need for dialysis or a 50% decline in the estimated glomerular filtration rate (eGFR) from baseline]. Conclusion The serum ATX levels in type 2 diabetic patients with diabetic nephropathy were associated with proteinuria and diabetic kidney lesions, although the serum ATX levels were not identified to be a predictive indicator for the renal outcome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26831013     DOI: 10.2169/internalmedicine.55.5473

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.

Authors:  Ming-Zhi Zhang; Xin Wang; Haichun Yang; Agnes B Fogo; Brian J Murphy; Robert Kaltenbach; Peter Cheng; Bradley Zinker; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

2.  Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder.

Authors:  Kei Itagaki; Minoru Takebayashi; Hiromi Abe; Chiyo Shibasaki; Naoto Kajitani; Mami Okada-Tsuchioka; Kotaro Hattori; Sumiko Yoshida; Hiroshi Kunugi; Shigeto Yamawaki
Journal:  Int J Neuropsychopharmacol       Date:  2019-04-01       Impact factor: 5.176

3.  Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy.

Authors:  Jong Han Lee; Phyu Phyu Khin; GwangHee Lee; Oh Kyung Lim; Hee-Sook Jun
Journal:  Aging (Albany NY)       Date:  2022-08-26       Impact factor: 5.955

Review 4.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.